U.K. under pressure to reimburse Novartis' Bexsero; Hepatitis B vaccine uptake in China drops;

> The U.K. health secretary is under pressure to add Novartis' ($NVS) Bexsero to the immunization program. Article

> Fears sparked by infant deaths drove a 30% drop in hepatitis B vaccinations in China in December. News

> Australian physicians have warned vaccination rates in some areas have fallen to worrying levels. Piece

> ILiAD Biotechnologies has formed a collaborative alliance to develop live attenuated Bordetella pertussis vaccine technology. Item

> As many as 70 Pakistani health workers have refused to take part in a polio vaccination drive because of security concerns. Post

> Bend Research is to present details of its attempt to create highly stable flu vaccines. Release

> PaxVax has presented interim data from a Phase III trial of its cholera vaccine candidate. News

> Galena Biopharma ($GALE) has partnered with Dr. Reddy's to commercialize its cancer vaccine candidate in India. Article